Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-21-044760
Filing Date
2021-03-31
Accepted
2021-03-31 16:16:12
Documents
74
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm211138d1_10k.htm 10-K 951081
2 EXHIBIT 10.53 tm211138d1_ex10-53.htm EX-10.53 22164
3 EXHIBIT 23.1 tm211138d1_ex23-1.htm EX-23.1 3045
4 EXHIBIT 31.1 tm211138d1_ex31-1.htm EX-31.1 10935
5 EXHIBIT 31.2 tm211138d1_ex31-2.htm EX-31.2 10641
6 EXHIBIT 32 tm211138d1_ex32.htm EX-32 6469
  Complete submission text file 0001104659-21-044760.txt   6267530

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acur-20201231.xml EX-101.INS 1455738
8 XBRL TAXONOMY EXTENSION SCHEMA acur-20201231.xsd EX-101.SCH 52938
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20201231_cal.xml EX-101.CAL 57375
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20201231_def.xml EX-101.DEF 197599
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20201231_lab.xml EX-101.LAB 379918
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20201231_pre.xml EX-101.PRE 370068
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10113 | Film No.: 21793520
SIC: 2834 Pharmaceutical Preparations